In addition, studies have shown that LCAT improves liver function in mouse models of HOD and alleviates liver fibrosis by promoting reverse cholesterol transport (RCT) from bone to liver (22). This evidence concerns the gene LCAT and hypopigmentation, organomegaly, and delayed myelination and development.